Dr. Mary E. Dahl, MD

Dr. Dahl practices at Community Hospital of the Monterey Peninsula in Monterey, California, part of Montage Health.

Dr. Dahl's NPI, 1255414991, was assigned on October 24, 2006. Dr. Dahl graduated from Loyola University Chicago Stritch School of Medicine in 1992. Dr. Dahl's California license number on file is G86138.

Dr. Dahl's primary practice is Community Hospital of the Monterey Peninsula, at 23625 W R Holman Highway, Monterey, CA 93940 in Monterey County. The practice phone is (831) 624-5311.

Dr. Dahl's primary practice is Community Hospital of the Monterey Peninsula in Monterey, California, part of Montage Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dahl practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dahl's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dahl is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dahl's licenses on file in 2 states: California and Wisconsin.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Dahl treats.

CMS data shows 10,402 Medicare services from Dr. Dahl across 15 procedure codes in 2024, for 1,371 Medicare patients. Medicare paid $484,976 for them. Every service was in an office.

CMS counts 1,371 Medicare patients who saw Dr. Dahl in 2024. The largest group is 75 to 84, with 684 patients. 75% of them have high cholesterol, and 61% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dahl's median patient age at 70, with 58% women.

In 2024, Dr. Dahl wrote 849 Medicare Part D claims for 402 patients. 98% of them were for generic drugs. CMS names the drug for 746 of them, across 17 drugs with 11 or more claims each, at $20,160 in total drug cost. In 2023, CMS named 713 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Dahl for performance year 2024, reported individually. Dr. Dahl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 4,519 procedures of removal of skin lesions by Dr. Dahl, more than 99% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 13 general payments to Dr. Dahl from 10 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 82% of the total. Janssen Pharmaceuticals, Inc paid the most, $124.

Dr. Dahl graduated from Loyola University Chicago Stritch School of Medicine in 1992.

Dr. Dahl is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.